STOCK TITAN

Apptly Health Tech (APTHF) Stock News

APTHF OTC
Rhea-AI Summary

Apptly Health Technologies (APTHF) announced a partnership with BioTrax AI to introduce preventive-care software to its network of independent physicians. The agreement covers introductions to more than 7,000 physicians in Apptly’s direct-pay healthcare marketplace. BioTrax AI’s platform combines laboratory testing, results management, tracking of health indicators over time, clinical workflows and automated documentation. A connected patient dashboard brings together health metrics, wearable-device data and secure physician-patient communication.

Apptly expects a phased rollout in the fourth quarter of 2026, supported by physician outreach, educational webinars and a marketplace presence. The partnership is non-exclusive, and adoption remains optional. Physicians’ listing, pricing and care-delivery practices on Apptly will remain unchanged.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-17.85%
Tags
partnership AI
-
Rhea-AI Summary

Apptly Health Technologies (APTHF) completed its national rebrand from UberDoc and launched paid physician and healthcare partner subscriptions on its rebuilt platform. Active paying members and partners are already enrolled. The transition unifies physician, partner, employer and government channels.

Physician memberships launched in October 2026. Government and agency examinations have generated recurring revenue supporting top-line growth since October 2026. Employer direct contracting remains in onboarding under a three-year agreement with Emphera Health signed in June 2026.

Management plans segment performance reporting beginning in Q1 2027, alongside updates on outpatient surgical integration and network growth. Apptly also engaged PCG Advisory for investor relations for an initial three months beginning November 4, 2026, at US$5,000 monthly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-27.78%
Tags
none
-
Rhea-AI Summary

Apptly Health Technologies (APTHF) completed the first tranche of its non-brokered private placement, raising gross proceeds of $726,450.

The company issued 5,811,600 units at $0.125 each, comprising one common share and one share purchase warrant. Each warrant permits purchase of one share at $0.25 for twelve months following October 6, 2026, subject to acceleration. If shares close at or above $0.35 for thirty consecutive trading days, Apptly may shorten the warrant term to thirty days after an announcement.

Apptly paid $2,975 in finder's fees and issued 23,800 broker warrants, exercisable at $0.25 for twelve months after closing, subject to acceleration. Interim CEO and director Paula Muto subscribed for $133,950.00 of units; an existing 10% shareholder subscribed for $100,000.00. Apptly expects a second tranche to close in the coming weeks, subject to customary closing conditions and any required regulatory approvals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.08%
Tags
private placement

FAQ

What is the current stock price of Apptly Health Tech (APTHF)?

Apptly Health Tech (APTHF) last closed at $0.0696.

What is the market cap of Apptly Health Tech (APTHF)?

The market cap of Apptly Health Tech (APTHF) is approximately $4.7M.